Scandinavian Journal of Rheumatology
Volume 53, 2024 - Issue 2
Letters
When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis
W-H Yoo1 Department of Internal Medicine, Division of Rheumatology, Jeonbuk National University Medical School, Jeonju, South Korea;2 Research Institute of Clinical Medicine of Jeonbuk National University – Biomedical Research Institute, Jeonbuk National University, Jeonju, South Korea
https://orcid.org/0000-0002-8430-7629View further author information
https://orcid.org/0000-0002-8430-7629View further author information, GW Ha2 Research Institute of Clinical Medicine of Jeonbuk National University – Biomedical Research Institute, Jeonbuk National University, Jeonju, South Korea;3 Department of Surgery, Jeonbuk National University Medical School, Jeonju, South Koreahttps://orcid.org/0000-0001-9401-1760View further author information
https://orcid.org/0000-0001-9401-1760View further author information, KM Kim2 Research Institute of Clinical Medicine of Jeonbuk National University – Biomedical Research Institute, Jeonbuk National University, Jeonju, South Korea;4 Department of Pathology, Jeonbuk National University Medical School, Jeonju, South Koreahttps://orcid.org/0000-0001-7074-7183View further author information
https://orcid.org/0000-0001-7074-7183View further author information & Y Choi1 Department of Internal Medicine, Division of Rheumatology, Jeonbuk National University Medical School, Jeonju, South Korea;2 Research Institute of Clinical Medicine of Jeonbuk National University – Biomedical Research Institute, Jeonbuk National University, Jeonju, South KoreaCorrespondence[email protected]
https://orcid.org/0000-0002-7922-0705View further author information
https://orcid.org/0000-0002-7922-0705View further author information